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Abstract 7 
Microneedle (MN) is a relatively recent invention and an efficient technology for transdermal 8 
drug delivery (TDD). Conventionally, the mathematical models of MNs drug delivery define the 9 
shape of the holes created by the MNs in the skin as the same as their actual geometry. 10 
Furthermore, the size of the MN holes in the skin is considered to be either the same or a 11 
certain fraction of the lengths of the MNs. However, the histological images of the MN treated 12 
skin indicate that the real insertion depth is much shorter than the length of the MNs and the 13 
shapes may vary significantly from one case to another. In addressing these points, we propose 14 
a new approach for modelling MN based drug delivery, which incorporate the histology of MN 15 
pierced skin using a number of concepts borrowed from image processing tools. It is expected 16 
that the developed approach will provide better accuracy of the drug diffusion profile. A new 17 
computer program is developed to automatically obtain the outline of the MNs treated holes and 18 
import these images into computer software for simulation of drug diffusion from MN systems. 19 
This method can provide a simple and fast way to test the quality of MNs design and modelling, 20 
as well as simulate experimental studies, e.g., permeation experiments on MN pierced skin 21 
using diffusion cell. The developed methodology is demonstrated using two dimensional (2D) 22 
numerical modelling of flat MNs (2D). However, the methodology is general and can be 23 
implemented for 3D MNs if there is sufficient number of images for reconstructing a 3D image 24 
for numerical simulation. Numerical modelling for 3D geometry is demonstrated by using 25 
images of an ideal 3D MN. The methodology is not demonstrated for real 3D MN as there are 26 
not sufficient numbers of images for the purpose of this paper. 27 
Keywords: Transdermal drug delivery, microneedles, numerical modelling and simulation, 28 
histological image, diffusion, Canny edge detection 29 
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1. Introduction 30 
Transdermal drug delivery (TDD) methods, which intend to deliver various drugs through the 31 
skin, need to conquer the outermost layer of the skin, namely, the stratum corneum (SC) [1]. 32 
Mathematical modelling of drug transport through the skin can provide important insights into 33 
TDD and it is considered to be important for analysing TDD as indicated by a large number of 34 
studies [2, 3]. This paper aims to report a new paradigm for numerical simulation of microneedle 35 
(MN) based drug delivery aided by histology of the MN treated skin. 36 
The importance of the physicochemical properties of solutes for transdermal permeation has 37 
been known since the early 1940s. But, it is only since the 1960s, i.e., when Higuchi first related 38 
these properties to passive diffusion in percutaneous absorption of drug molecules [4] using 39 
Fick’s first law of diffusion that modelling diffusion of drugs for TDD has been seriously 40 
attempted. Based on the diffusion law, many researchers have now simulated drug transport 41 
from different technologies that can enhance the TDD [5]. MN technology is a promising method 42 
and it is increasingly being explored for controlled enhancement of TDD of different molecules 43 
[6, 7].  44 
The first MN modelling paper aimed to aid design of hollow MNs for fluid extraction [8]. Since 45 
then, various researchers have focussed on improving the accuracy of simulation by 46 
incorporating important fundamental features of the behaviour of MNs for drug delivery, thereby, 47 
achieving better prediction of the drug diffusion behaviour [9, 10]. For example, the geometry 48 
and size of the MNs, which are important factors, have been considered in a number of 49 
previous modelling studies because they determine the drug diffusion rate and flux from the 50 
MNs [11]. Consequently, optimization of the MNs geometry, shape and size of the MNs has 51 
been attempted by many researchers, so that the desired TDD rate can be identified for specific 52 
case [12]. These frameworks demonstrate that the patterns of MNs and alignment of these MNs 53 
on the patch are important to provide a sufficient delivery rate of drugs [13].  54 
Overall, it seems that the simulations for MNs based drug delivery are helpful for design of MNs 55 
and understanding how they function but these require results of high quality and accuracy. 56 
Generally, the current researches on MNs modelling idealize the size and shapes of the MN 57 
holes (i.e., the computational domain) which are created by the MNs and often it is assumed 58 
that the size of the holes are the same as the MNs themselves or a certain fraction of the 59 
lengths of the MNs. However, the histological images of these holes indicate that the shapes of 60 
MNs and their associated holes may be very different [14]. Not only the lengths of the MNs 61 
pierced holes vary in length from case to case but also their shapes may vary. From the point of 62 
view of TDD, this implies that the drug delivery rate should vary from case to case. This can 63 
become a crucial factor that causes inaccuracy in the simulation results. For these reasons, this 64 
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paper aims to develop a new paradigm in numerical simulation for drug delivery by MNs which 65 
can incorporate the shapes and sizes of the MNs holes as determined from the histological 66 
images of MNs treated skin. It is hypothesised that more realistic simulated drug transport 67 
behaviour (e.g., transient drug concentration profile) can be obtained by averaging simulation 68 
results from a number cases given by different histological images for the same circumstance 69 
(e.g., the same skin, MN length and drug molecule), coupled with experimental data (e.g., 70 
diffusion coefficient of the drug or drug permeability) for the corresponding case.  71 
In addressing this issue, this paper introduces a new approach that should improve the 72 
simulation accuracy of MNs based drug delivery. We present a numerical model based on the 73 
histological images of MNs treated skin instead of using the conventional method [15] which 74 
considers the geometry of MNs in conjunction with a correction factor to determine the lengths 75 
of the holes. There are several advantages of using these images, as discussed below.  76 
When we consider the histological images and couple them with experimentally determined 77 
parameters (e.g., drug diffusion coefficient) for modelling the drug transport, the deformation of 78 
the skin due to insertion of MN [9, 16], which affects the drug transport behaviour, will be 79 
directly accounted for. Most MN drug delivery simulations tend to ignore the effects of skin 80 
deformation as it is governed by the geometry of the MNs, force exerted on the MN patch and 81 
viscoelastic properties of the skin, thereby, making skin deformation and its effect on drug 82 
transport a difficult quantify to determine. However, there are several researches which focused 83 
on studying the factors that can cause skin deformation, e.g., the MN insertion force has been 84 
decomposed into several components to increase the accuracy of the simulation [16]. Similarly, 85 
the viscoelastic properties of the skin layers have been considered [17]. The histological images 86 
provide a view of the holes created by MNs on skins. For the same cases, experimental data on 87 
drug permeation and effective diffusion coefficient can be obtained. The accuracy of the 88 
information can also be increased by acquiring a number of these images and experimental 89 
data. As stated earlier, it is hypothesised in this paper that these information can then be used 90 
to carry out more accurate numerical simulations for MN based drug delivery.  91 
The histological image can provide an efficient way to evaluate the practicability of the MNs 92 
modelling and, the images may be acquired irrespective of the source or the method of 93 
acquiring them. For example, the cross-sectional view of the MNs treated skin can be acquired 94 
by using a cryotome and then viewed under a microscope [18]. Similarly, technologies such as 95 
optical coherence tomography (OCT) [19, 20] and micro-CT [21] have been useful in obtaining 96 
images of MN pierced skin. These images can show whether the pathways (holes) created by 97 
the MNs are adequate in overcoming the SC and for a target drug molecules to pass through.  98 
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In order to analyse the drug transport behaviour based on the histological images, a MATLAB 99 
program has been developed in this work which can automatically acquire the coordinates of 100 
various points of the image of the skin sample. These coordinates (i.e., not the image) can then 101 
be imported into a simulator (e.g., commercially available software COMSOL [22]) to carry out 102 
the desired simulations for drug transport.  103 
2. Histology of MNs treated skin as computational domain for numerical simulation 104 
 105 
2.1 Acquisition of images of MNs pierced skin  106 
In this work, the computational domain for the numerical simulation is based on the histological 107 
images which can expose the cross-sectional views of MNs treated skin. The images are 108 
collected using porcine ear skin purchased from local abattoir [23]; however, the developed 109 
methodology is general and it would work with images collected via any other means.  110 
The skin samples are freshly harvested and flash frozen using liquid nitrogen after sectioning 111 
and kept in the freezer at -20ºC if they are not used immediately after collection. The sample 112 
are wrapped in aluminium foil and left in room temperature to defrost for 2 hr before an 113 
experiment. The skin are cautiously separated from the underneath cartilage using a surgical 114 
scalpel.  115 
1100µm/1400µm long MN patches which are purchased from nanoBioSciences (Sunnyvale, CA, 116 
USA) are used to pierce the skin. The insertion depths of these commercial MNs patches (~ 117 
400 – 500 µm) are much shorter than the actual lengths of the MN as the insertion depths 118 
depend not only the actual MN lengths but also the force of insertion, MN density of the patches 119 
and viscoelasticity of the skin.  These have been demonstrated in our previous paper [24] and 120 
are not discussed here.  121 
A MNs patch is pushed with a relatively high thumb pressure to ensure that all the needles are 122 
pierced into the skin and then mounted to a pneumatic pump with a constant 1MPa pressure for 123 
10min. The sectioning protocol for the prepared skin sample using cryotome (Fig. 1) is 124 
consistent with our previous study and is not discussed in detail in this paper [25]. The sample 125 
of sliced skin is then analysed under a microscope and a number of images are taken using a 126 
camera which is attached to the microscope. The acquired images are processed for numerical 127 
simulation as discussed below.  128 
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 129 
2.2 Processing of skin histological images for numerical simulations 130 
An image of the skin histology cannot be directly used as a computational domain for numerical 131 
simulations as the skin layers/surfaces needs to be identified in terms of co-ordinate points. 132 
Furthermore, due to the possibility of a number of other factors which affect the quality of the 133 
original image for simulation purpose, the developed algorithm is designed to eliminate these 134 
factors. These are discussed separately in the latter part of the paper.  135 
 136 
Fig. 1 A cryotome setup which was used to acquire the histological images of the MN pierced 137 
skin. The skin sample is wrapped in glue, fixed on the sample holder between the blade and 138 
anti-roll guide plate, and sliced into think sections.  139 
Once the images of the cross-sectional view of the MN pierced skin samples are captured, all 140 
the images are imported into MATLAB (Natick, MA, USA) for processing [26]. In this work, an 141 
in-house MATLAB program was developed to process these images. The first step of this 142 
program is to acquire all the edges of the image. To achieve this, all RGB images (conventional 143 
format using red, green and blue added on each other to reproduce all colours) need to be 144 
converted into grayscale images. A Canny edge detection algorithm [27] is then applied on the 145 
grayscale images to acquire the edges of the individual images. A Canny algorithm is an 146 
advanced image filter based on a Gaussian filter [28]. It involves four stages, namely, (i) noise 147 
reduction, (ii) edge detection, (iii) edge thinning, and (iv) thresholding with any hysteresis, which 148 
provide high quality edges of computational domain in a black and white map. Two examples of 149 
images of skin pre-treated with MN, which have been processed with the Canny algorithm using 150 
the developed MATLAB code, are shown in Fig. 2. From the figure we can see that the edges of 151 
the original images are acquired with high quality details. However, in reality, we do not need all 152 
Anti-roll 
guide plate 
Skin sample 
Blade 
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the details in different skin layers as well as the debris outside the skin which do not have any 153 
significance for the drug transport. Furthermore, the presence of debris may influence the 154 
numerically determined transport behaviour. Therefore, the images obtained are further 155 
processed by specific algorithms to acquire smoother profiles of the skin layers/surfaces.  156 
 157 
Fig. 2 Two examples of histological images of skin pierced with MNs (images on the right) 158 
which are treated with the Canny edge detection algorithm (images on the left) for further 159 
processing and numerical simulations. 160 
 161 
2.2.1 Different steps adopted for smoothing the images of skin histology for numerical 162 
simulation 163 
The algorithm for preparing the geometry of the computational domain for numerical simulation 164 
is consisted of four stages: (i) the image dilation and fill, (ii) debris identification, (iii) debris 165 
elimination and (iv) importing domain as computational domain for numerical simulation. When 166 
all four stages are finished, the acquired geometry of the domain is expected to be ready as a 167 
computational geometry for numerical simulations.  168 
2.2.1.1 Dilation and filling 169 
Firstly, the edges acquired from the edge detection process need to be dilated to connect any 170 
gaps on the skin surfaces. It is a necessary step to accomplish an intact domain for numerical 171 
simulation from discrete lines as shown in Fig. 2 [29]. From a number of trials we have 172 
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concluded that a 5 pixels×5 pixels dilation matrix is sufficient to connect all the gaps in the 173 
images that we have collected. However, this matrix may be different in another case where the 174 
image of the skin histology is significantly more complicated and requires significant amount of 175 
dilation and filling. To achieve higher accuracy, the size of the matrix, represented as ‘se’ in this 176 
paper, can be modified in the developed program. After all the gaps have been connected, 177 
there may be still some undesired sections (e.g., holes or unconnected parts) left in the image, 178 
which need to be filled, as otherwise they would impede the process of the skin layer acquisition 179 
and numerical simulations. The boundary of the domain also needs to be defined according to 180 
the profile of skin surface before the ‘image fill’ process. 181 
2.2.1.2 Debris identification 182 
As discussed above, after the computational domain (an image) has been confirmed, there may 183 
still be some undesired skin debris in it. The debris can be hard to predict in the images 184 
because they can be constituted by loose debris of the skin sample (e.g., generated while the 185 
skin is pierced) as well as by other impurities or bubbles in the embedding compounds (e.g., 186 
gels used for acquiring cryotome images). The MATLAB program has been developed to 187 
automatically identify all kinds of debris so as to smooth the images irrespective of their sources.   188 
For the purpose of debris identification, the debris in the image is discriminated from the main 189 
body of the skin sample and the debris is identified individually by the program. After the debris 190 
is identified, an elimination program is launched to remove the debris. This stage of the 191 
developed program is designed to remove debris from the image without causing any damage 192 
to the computational domain of interest. Our method shows great advantages comparing to 193 
other filtration methods (such as using rank or Gaussian filtering methods to remove debris) 194 
whichcan cause great damage to the outline of the skin [30]. Fuller details of the debris 195 
elimination program will be introduced in section 2.2.1.3. 196 
2.2.1.2.1 Specifying corners of the debris in terms of co-ordinates 197 
The debris identification stage is based on the assumption that the debris has closed 198 
edges/boundaries. In other words, if a point on the edge of debris moves along its edge, it will 199 
eventually come back to the same point where it started. This is an important factor in the 200 
developed algorithm so as to discriminate the debris from the skin sample and confirm which of 201 
the target debris is to be eliminated. If we choose a corner of the debris as the starting point, 202 
this point will then go from corner to corner and finally reach the original corner. Therefore, we 203 
need to classify the moving patterns between the corners. To explain this process a logic 204 
diagram is shown in the Fig. 3. In the figure, the capital letters L/R/U/D/T/B/P/N represent the 205 
initial alphabets of words left/right/up/down/top/bottom/positive/negative, respectively, which 206 
represent how a position moves in the algorithm to identify the debris. For example, the 207 
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combination of LTP indicates the following: (1) the current point is on one of the left (L) top (T) 208 
corners of the image; (2) the points on its lower right havetheir pixel intensity values equal to 209 
posititive (P) 1.0; and (3) positive represents the direction of the edge detecting process passing 210 
this point is clockwise (while negative represents counter-clockwise). In contrast, the LTN points 211 
satisfy the inverse of the above three conditions for LTP points. A schematic diagram to explain 212 
the differences between the LTP and LTN points has been shown in Fig. 4.  213 
2.2.1.2.2 Principles for the identification of debris 214 
In this section, we discuss the principles and the mechanism of the debris identification process 215 
in more detail. The developed MATLAB program starts from LTP which could be a positive left 216 
top corner of a domain of any shape. To define a corner in an image, we define that a minimum 217 
number of four points are required. In this specific case at point (x,y), a LTP can be confirmed if 218 
it satisfies the following four conditions: (x+1,y-1)=0; (x,y-1)=0; (x-1,y-1)=0 and (x-1,y)=0 (for a 219 
800x600 image, the coordinate from left top to left bottom is x=0 to x=600, from left top to right 220 
top is y=0 to y=800). Once a LTP point is chosen, there are two initial conditions that should be 221 
satisfied for this program. Firstly, LTP is chosen as the only criterion being both the starting 222 
point and terminal point, and secondly, it is defined that the first move from LTP is always to the 223 
right direction (clockwise). From Fig. 3 we can see that there are only two destinations if a LTP 224 
point moves to the right following the edges, i.e., RTP and RBN. If a point reaches the RTP, 225 
then it can only move downward to either RBP or LBN. An example edge detection process has 226 
been shown in Fig. 5.  227 
Although there are 8 different corners involved according to Fig. 3, they are all connected to the 228 
four terminals which are marked with different colours. They are LTP/RTN/LBN/RBP marked 229 
with red/purple/blue/green, respectively. However, only the red LTP is the real terminal. . When 230 
the process reaches red LTP, a check must be made to compare the current point to the 231 
original one. If they are the same point, it indicates that the edge detection process has been 232 
done because the selected point has travelled the entire surface of the debris and back to its 233 
original position again. If not, the process will go back to LTP○1  and continues until it reaches 234 
the original point. The circle enclosed number represents pathway 1 which is connecting LTP to 235 
either corner RTP or RBN. These pathways can keep the edge detection process to stay on the 236 
edge. Otherwise, the process may never move from one corner to another.  237 
When the edge detection process reaches other three terminals, it will jump back to the 238 
previous junction that has the same colour with that terminal, for example, all purple RTN 239 
terminals will jump back to junction purple RTN○6 . An illustration of a simple loop starting from 240 
junction RTN○6 , which moves to terminal RTN following the edge of the shape and then jumps 241 
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back to junction RTN○6 , has been shown in Fig. 6. Where the blue and black arrows represent 242 
the process conducted in logic diagram and reality, respectively. When the process jumps back 243 
to the junction RTN○6 , the point will move to the left again until it reaches the terminal LTP. All 244 
three coloured junctions connect to a LTP terminal to avoid falling into infinite loops.  245 
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 246 
Fig. 3 A logic diagram of edge detection algorithm: L=left, R=right, U=up, D= down, T=top, B= bottom, P=positive, N=negative. Circle enclosed 247 
number represents pathways connected to specific corners.248 
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 249 
Fig. 4 A schematic diagram to demonstrate the differences between a LTP point and a LTN point 250 
(each square in the diagram represents one pixel in the image). 251 
 252 
                   253 
Fig. 5 A schematic diagram which shows two possibilities for a point while moving from LTP to 254 
either RTP or RBN (each square in the diagram represents one pixel in the image). 255 
2.2.1.2.3 The definition of hidden corners 256 
In some cases, there are corners which are not easy to distinguish from the shape because the 257 
definition of a corner in this program and it may not be possible to assign co-ordinates precisely 258 
to each point. This is because these corners are concealed in the shape or overlapped with other 259 
points. However, they can be found by the edge detection process. The reason for the existence 260 
of these hidden corners is that the trajectory of the edge detection process is not always straight. 261 
When the trajectory is terraced, the corner will appear as irregular. An illustration of hidden 262 
corners RBN and RTN in edge detection process has shown in Fig. 7.  263 
 264 
 265 
LTN 
LTP 
LTP RTP 
LTP RBN 
Accepted in Journal of Pharmaceutical Sciences 
 
Page 12 of 30 
 
 266 
Fig. 6 An example of a typical case in which the debris identification process reaches a terminal 267 
(see Fig. 3) where it will automatically jump back to its corresponding junction (each square in 268 
the diagram represents one pixel in the image).  269 
 270 
Fig. 7 Illustration of two hidden corners existing in this example figure, which are RTN and RBN 271 
formed due to terraced edge (each square in the diagram represents one pixel in the image). 272 
The corners LTP and LBP are easy to identify but the corners of RBN and RTN are likely to be 273 
anomalous. Nevertheless, the RBN and RTN can be recognized by the program, and therefore, 274 
the developed MATLAB code will ensure that the edge detection process will not be affected. 275 
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2.2.1.2.4 Special cases in the process of identifying corners  276 
A special circumstance needs to be clarified when the edge detection process runs back to LTP 277 
from the only two possible corners: LBP and RBN. Three representative cases have been shown 278 
in Fig. 8: 279 
 280 
Fig. 8 Three special cases in the edge detection process which need to be identified individually 281 
in the program by the user (each square in the diagram represents one pixel in the image). 282 
The first and second cases in Fig. 8 show that when the edge detection process moves up from 283 
LBP and RBN to LTP corner, the program will not be able to recognize the LTP corner according 284 
to the logic diagram. The program will ignore the LTP corner and move on to follow the dashed 285 
arrow. The third case shows an extreme circumstance in which the LTP corner overlaps the LBP 286 
corner and the program will go on following the dashed arrow. The reason for this situation is due 287 
to the fact that when we define the LTP corner, we have used four points. However, only three 288 
points have been used to profile the pathways. The problem for all other corners has been solved 289 
by applying the ‘hidden corner’ concept which has been mentioned previously. But the LTP 290 
corner is different because the program may have to be terminated here. To solve this special 291 
case, an additional step must be introduced to compare the current LTP corner to the original 292 
one. Once the left top corner is confirmed as the same one of the original corner, it indicates that 293 
one of the debris has been identified so that the corresponding elimination process will be 294 
triggered.  295 
2.2.1.3 Debris elimination 296 
Once all the debris has been identified, the program will jump to the elimination stage 297 
automatically to remove the skin debris. As mentioned before, a conventional image filter cannot 298 
be applied here due to the inaccuracy [31]. Therefore, the elimination process is specially 299 
designed which shares the same logical diagram with the debris identification process. However, 300 
the elimination process will erase every point that the moving point Y has passed through. 301 
Therefore, the program will not stop until the last point of the debris is eliminated because the 302 
starting point has already been erased at the beginning. The elimination program peels off the 303 
debris shape layer by layer and jumps back to the debris identification program once the process 304 
is finished. An illustration of the elimination process is shown in Fig. 9.  305 
LTP 
LBP 
RBN 
LTP 
LTP&
LBP 
RTP 
RBP 
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 306 
Fig. 9 An illustration of the debris elimination process (each square in the diagram represents 307 
one pixel in the image). 308 
The elimination process begins from the starting point which is a LTP corner of the shape and 309 
will be at the middle point of the shape that marked in light grey colour. However, the elimination 310 
process may not be able to finish in one go because sometimes the shape will be broken into 311 
several small blocks. It happens when the connection point is erased so that the moving point Y 312 
cannot go back to the original block to finish the elimination process. To solve this problem, the 313 
identification process is always scanning line by line from top to bottom. Once the first starting 314 
point is identified, the program will jump to elimination process to remove the debris. After the 315 
elimination, the identification program will scan the next line and find the second starting point to 316 
remove the remaining part of the debris. The illustration is shown in Fig. 10.  317 
 318 
Fig. 10 An illustration for the special elimination case, first starting point, second starting point 319 
and the connection points are marked with light blue, pink and grey, respectively (each square in 320 
the diagram represents one pixel in the image). 321 
To increase the speed of the program, a global parameter ‘si’ is set to describe the maximum 322 
size of debris. The ‘si’ parameter is pre-set to 30 in this work, which means that the maximum 323 
size of debris in an image is equal to or smaller than 30x30 pixels. After all debris are identified 324 
and eliminated, the program will move to the next stage and the treated image compared to the 325 
untreated image is shown in Fig. 11.  326 
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3 Numerical simulations using processed image 327 
3.1 Acquiring processed image in numerical simulator 328 
After the debris identification and elimination process, the image shows clear outline of the skin 329 
sample without the interference of the debris. The program then captures the profile of the skin 330 
by picking up all the points on the boundary. The thickness of the profile is defined to be one 331 
pixel and the acquired profile will be saved in a matrix.  332 
 333 
Fig.11 Two pairs of typical images before (left) and after (right) treating with debris identification 334 
and elimination stages. The two images on the right hand (top and bottom images) side are now 335 
ready to be used as computational domains for numerical simulation. 336 
To carry out the diffusion analysis, the profile of the skin is imported into a commercially available 337 
FEM software (COMSOL) in this work. However, it can be imported to any numerical software or 338 
environment. All the coordinates of the points that are required for geometry are saved in a [n,2] 339 
matrix and the order of the coordinate of points are also properly reorganized. To achieve the 340 
same geometry between the computational domain in the FEM software and the imported 341 
domain, the rearranged coordinate in the matrix must represent adjacent points in the image. 342 
After the profile of the skin surface has been acquired, the computational domain is converted 343 
into computational geometry whose boundary is consisted by coordinate of points (instead of 344 
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boundary lines as seen in an image). This imported geometry is then meshed for numerical 345 
simulation. An example of a numerical mesh is shown in Fig. 12. The coordinates of all points in 346 
the mesh are saved in a .txt file by the program, so the simulation can be done using any 347 
software. There is only one task that needs to be done by the users themselves, which is to find 348 
the ratio between the pixel and scale of the actual image. This requires user to set up a scale 349 
when they obtain an image using camera, micro-scope, OCT or micro-CT or any other source. 350 
After the scale is known, the ratio can be easily calculated by an image processing software. 351 
 352 
Fig. 12 A typical image of a histological image which is meshed for numerical simulation 353 
3.2 Governing equations  354 
As discussed earlier in our papers, an effective skin thickness can be defined for MN treated skin 355 
which represents the average path length for drug diffusion through the skin [32, 33]. Using the 356 
same concept, we calculate the effective thickness in this work using the images that we have 357 
collected. We define that there is negligible change on the diffusion coefficient in viable epidermis 358 
due to insertion of MNs and the diffusion profile of drug molecules passing through the skin at 359 
steady state is obtained using the Fick’s first law:  360 
𝑵𝒊 = −𝑫𝒊𝛁𝑪𝒊 (1) 
Where Ni is the flux, the Di is diffusion coefficient, Ci is the concentration. In the simulation of 361 
MNs treated skin and the thickness of the skin change, so the effective thickness of the skin is 362 
introduced in consistent with our previous studies [32, 33]. Therefore, we deduce the diffusion 363 
coefficient from the experiment data of passive diffusion and the effective thickness in this study 364 
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can be simply considered as reduction of the real skin thickness. The real skin thickness is 1.6 365 
mm which is the average over 20 randomly selected samples. An effective thickness of the MNs 366 
treated skin is then calculated using equations (2) and (3) as discussed earlier [33]. 367 
𝑫𝑷𝑫 =
𝑱𝑷𝑫𝒉
∆𝑪
 
𝒉𝒆𝒇𝒇 =
𝑫𝑷𝑫∆𝑪
𝑱𝑴𝑵
 
(2) 
(3) 
Where JPD is the flux from passive diffusion, JMN is the flux from MNs treated diffusion, DPD is the 368 
diffusion coefficient of the skin and heff is the effective thickness of the MNs treated skin. We use 369 
the steady state model to analyse the experimental data because it is impossible to know the 370 
drug concentration at any position of the skin at any time point. However, the numerical 371 
simulation is able to provide simulated data at any specific time point and depth [34].  372 
Once the effective skin thickness has been identified, we apply Fick’s second law in order to 373 
build a transient drug diffusion model: 374 
𝜕𝑐𝑖
𝜕𝑡
+ ∇ ∙ (−𝐷𝑖∇𝑐𝑖) = 𝑅𝑖              (4)  375 
Where ci is the drug concentration, D is the diffusion coefficient, t is the time point and Ri is a 376 
constant.  377 
The 1D boundary conditions to solve the differential equations (1) and (4) are: 378 
 379 
(5) 380 
 381 
Where C1 is the constant drug concentration we give on the skin surface, C2 is the drug 382 
concentration at the bottom of our skin model, x is the distance between skin surface and a 383 
specific point in the skin, h is the thickness of the skin. For transient simulations, C2 is set to zero 384 
at the beginning and its cumulative values over time will be calculated using equation (4) until 385 
steady state is reached. In order to solve the differential equations (in 2D or 3D), additional 386 
boundary conditions should be applied to equations (1) and (4):  387 
−𝒏 ∙ 𝑵𝑖 = 0 at plane y = 0, l and z = 0, w (at all t for transient drug transport) (6) 
Where n is the normal vector to the plane, Ni is the flux, y is the length between the front surface 388 
of the model and a specific point in the skin in longitudinal direction and the total length is l, z is 389 
C = C1 at x = 0 (for all t for transient drug transport), 
C = C2 at x = h (for all t for transient drug transport), 
C = 0 for 0 < x < h  (at  t = 0 for transient drug transport) 
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the width between the left surface of the model and a specific point in the skin in horizontal 390 
direction and the total width is w. The governing equations are implemented in commercial 391 
software COMSOL by importing the coordinates of the points on the skin surface and choosing 392 
the element sizes for different accuracy scales of FEM mesh. The parameters that are needed 393 
for the simulations can be either acquired from experimental data or using the theoretical values 394 
(e.g., correlations). If the transient model is applied which refers to equation (4), COMSOL can 395 
show the diffusion results at any time point before it reaches the steady state.  396 
4. Results and discussion 397 
4.1 Calculation of MN insertion depths based on histological images 398 
Four histological images of MNs treated skin samples have been chosen for both 1100µm and 399 
1400µm long MNs. The insertion depth of each image is then calculated using ImageJ software 400 
(Bethesda, MA, USA) [35] and the mean insertion depth of each group has been calculated. It is 401 
found that the average insertion depth of 1100µm and 1400µm long MNs are 0.53±0.054 mm 402 
and 0.7435±0.099 mm, respectively.  403 
The theoretical insertion depth refers to the length of the MNs which are 1.1 mm and 1.4 mm, 404 
respectively. The full skin thickness is a constant value of 1.6mm, which is mentioned in the 405 
previous section.  406 
The experimental data are obtained from our previous study effects of MNs on the permeability 407 
of insulin in skin [25]. Since a drug molecule that is larger than 500 Da cannot pass through the 408 
SC layer passively [36], we define that the diffusion coefficient for insulin (MW: 5808 Da) in the 409 
SC layer is negligible. The histological images also indicate that the MNs partially break the SC 410 
layer and mass transfer distance between the drug solution and the receptor compartment in a 411 
FDC is reduced. Therefore, the complex situation where the SC layer is involved will not be 412 
discussed in this paper and it is defined that the skin layer below the SC is the most relevant for 413 
modelling the drug delivery process. For this reason, we consider our skin model as one layer. 414 
Furthermore, we compare the passive diffusion in VE and diffusion in MN treated VEby using the 415 
diffusion coefficient of the viable epidermis. Based on these assumptions and data from our 416 
previous study, the diffusion coefficient (DPD) is calculated as 1.3e-12 m²/s and the effective 417 
thickness of both MNs are deduced accordingly by applying equations (2) and (3), respectively. 418 
The insertion depths and skin thickness results acquired for insulin are shown in Fig. 13. 419 
As shown in Fig. 13, we compare the full skin thickness with the calculated effective thickness of 420 
the skin, theoretical insertion depths (i.e., length of individual MN) and average MN insertion 421 
depths based on histological images. The results show that the effective thickness (and hence, 422 
Accepted in Journal of Pharmaceutical Sciences 
 
Page 19 of 30 
 
the mean path length for drug diffusion) is larger than the MN insertion depths based on the 423 
images but smaller than the MN lengths or real skin thickness.  424 
 425 
 426 
Fig. 13 Two sets of comparison: full skin thickness compared to the effective thickness after MNs 427 
insertion. The theoretical insertion relates to the insertion depth calculated from histological 428 
images. The effective thicknesses were calculated using data from insulin permeation study for 429 
1100µm (top) and 1400µm (bottom) long MNs.  430 
4.2 Numerical simulation of drug permeability/diffusion  431 
4.2.1 Testing developed scheme for an ideal MN geometry  432 
In order to test that the developed algorithm performs, we attempt to simulate an ideal geometry 433 
of MN (Fig. 14A) and define that the holes created by them in the skin match their size and 434 
shape. Therefore, the MN holes are well defined in terms of shapes and size (Fig. 14) and have 435 
no debris in the image, making them a good model to test that the developed scheme is working. 436 
As obvious, the modelling does not involve the use of a histological image in this case and the 437 
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simulation is done using the image of the MN geometry (0.5mm long) with some bends and 438 
complex features. We define that such a MN system has been applied according to a ‘poke and 439 
patch’ approach where the MNs have been applied on the skin, removed after creating the MN 440 
holes and a drug is then applied on the skin which penetrate into the holes. The drug molecule 441 
then diffuses into the skin through the viable epidermis. In effect, we simulate the drug 442 
permeation study in a typical Franz diffusion cell as discussed earlier [23].  443 
The data for permeation of insulin from our previous experiment using Franz diffusion cells [25] 444 
have been chosen to carry out the numerical test. The drug concentration on the skin surface is 445 
set to a constant value of 1000ppm and the bottom surface of the skin is set as zero 446 
concentration which indicates a static system such as those seen in the receptor compartment in 447 
a Franz diffusion cell. The time duration insulin is defined to be 48 hr.  448 
Fig. 14 and Fig. 15 show some of the results obtained for the case above. In Fig. 14 (C,D) we 449 
show the mesh used for the numerical simulation and concentrations distribution in the MN 450 
treated skin at steady state. Figure 15 shows the numerically calculated insulin concentration in 451 
the receptor compartment of a Franz diffusion cell with and without MN. The results indicate that 452 
insulin (molecular weight: 5808 Da) reaches 10% of its maximum concentration in the receptor 453 
compartment in FDC after 48 hr. It has also shown that MNs cause great effects on large size 454 
molecules because the trend lines between MNs enhanced diffusion and passive diffusion are 455 
distinct. 456 
4.2.2. Numerical simulation of insulin permeation in a Franz diffusion cell  457 
In this section, we will illustrate modelling using the image acquired from cryotome sliced skin 458 
sample captured by a microscope camera. The original and processed images are shown in Fig. 459 
16. The simulation is then employed based on those 2D histological images. The MNs we 460 
applied are flat in structure with negligible thickness; therefore 2D images are sufficient for this 461 
study. However, the methodologies are general and therefore they can be applied for MN of any 462 
shapes and sizes provided their histological images are available.  463 
The same initial and boundary conditions as discussed earlier are again applied for the purpose 464 
of this section. The numerical results for insulin concentration in the receptor compartment of a 465 
Franz diffusion cell are shown in Fig. 17. The insulin delivery has been shown higher amount of 466 
drug permeated and reduced lag time (time from initiation to the steady state). The simulated 467 
data from all the histological images are now averaged and compared with the experimental 468 
results of insulin from our previous study [25]. The initial concentration of the drugs and time 469 
durations of the simulation remain the same with the experiment condition. The results are 470 
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shown in Fig. 18. From the figure we can see that that the predicted concentration of insulin 471 
resembled well to the experimental results.  472 
 473 
Fig.14 The process after the image is input into the program. A) The original image; B) The 474 
outline of the skin has been captured; C) The skin thickness has been adjusted to 1.6mm and the 475 
mesh using FEM has done; D) the simulation of the diffusion profile of the target drug molecule 476 
(insulin, in this study) 477 
  478 
A 
 
B 
 
C 
 
D 
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 479 
Fig.15 Insulin concentration profile of the passive diffusion and MNs enhanced diffusion based 480 
on the ideal geometry in Fig 14.  In both cases, only permeation in viable epidermis is considered.  481 
 482 
Fig. 16 The image from cryotome sliced skin is processed by program and simulated in 483 
COMSOL. A) The original image; B) The outline of the skin has been captured; C) Simulated 484 
diffusion profile of the target drug molecule (insulin, in this paper) 485 
A 
 
B 
 
C 
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 486 
Fig. 17 The diffusion profile of the passive diffusion and MNs enhanced diffusion based on the 487 
imported model. Insulin concentrations in the receptor compartment of FDC have been 488 
calculated. In both cases, only permeation in viable epidermis is considered.  489 
 490 
Fig. 18 Numerical simulation data compared to the experimental results from our previous papers 491 
[25]. The concentration profiles of insulin are presented.  492 
4.2.3. Numerical simulation using images obtained from the literature  493 
The third modelling scenario is based on a complex OCT image which we have collected from a 494 
published paper [37]. The OCT image has much lower resolution level than the images taken by 495 
the in-house camera in this study. Despite this, it is observed that the developed algorithm can 496 
depict the outline of the skin surface without losing significant details. The numerical modelling 497 
results using these images have been shown in Fig. 19. The image in this case shows that the 498 
MNs create lower insertion depth but more holes than previous images. Assuming that the MNs 499 
in this example are used to carry out an insulin permeation study, the same boundary conditions 500 
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are applied again on this image. The insulin concentrations in the receptor compartment of a 501 
FDC are shown in Fig. 20. The concentration profiles indicate that although the numbers of the 502 
holes increased as MNs are pierced into the skin, the diffusion rate is low compare to the passive 503 
diffusion. This also suggests that simply increasing the number of the MNs will not greatly 504 
increase the permeability in this case. The insertion depth and the geometry of the MNs may 505 
present higher impact to the diffusion rate. 506 
 507 
Fig.19 The OCT image is processed by the program and simulated in COMSOL. A) The original 508 
OCT image; B) The outline of the skin has been captured; C) the simulation of the diffusion 509 
profile of the target drug molecule [37]. 510 
B 
 
A 
 
C 
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 511 
Fig. 20 The diffusion profile of the passive diffusion and MNs enhanced diffusion based on the 512 
model of Fig. 19. Insulin concentrations at receptor compartment of FDC have been calculated. 513 
In both cases, only permeation in viable epidermis is considered so as to have a meaningful 514 
comparison. 515 
4.2.4. Numerical simulation of insulin permeation in 3D  516 
The last case is an extension from the first scenario where we attempted to demonstrate 517 
simulation of 2D structured MNs. There are plenty of previous studies which have used 3D MNs 518 
model to simulate diffusion in TDD [38]. However, our 3D model is constructed from the pores 519 
created by MNs instead of building a model using the shape of MNs. Different slices of 520 
histological images from one MN cavity are combined to form a 3D model of the MN cavity and 521 
the accuracy of the reconstructed MN cavity will increase when more slices are involved. In this 522 
case, we choose the sample shape from Fig. 14 as the standard to maintain the consistency and 523 
illustrate the process by including another 8 slices to construct the 3D model. The profile of each 524 
sample slice is acquired using previous method and then all slices are imported to COMSOL as 525 
individual surfaces which are shown in Fig. 21. After all sample slices are imported into COMSOL, 526 
triangular and quadrilateral surface elements are created to connect one slice to its adjacent 527 
slices (Fig. 22A). These connected slices are then knitted into one complete solid computational 528 
domain and meshed using FEM, so the 3D boundary conditions from equation (5) and (6) can be 529 
applied accordingly (Fig. 22B). The same concentration (1000 ppm of insulin solution) is applied 530 
on the top surface of the model and the cumulative concentrations at the bottom surface are 531 
recorded for 48h with a 4h interval (Fig. 22C).  532 
 533 
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 534 
Fig. 21 The sample slices have been acquired individually and then imported into COMSOL. A) 535 
The profile of the sample slice from Fig. 14 which is located in the middle of all slices; B) Another 536 
sample slice located next to the standard; C) All 9 slices are imported into COMSOL for further 537 
study. 538 
 539 
Fig. 22 The process of 3D modelling using sample image slices. A) Two adjacent slices are 540 
connected by surface elements; B) All slices are knitted to solid and meshed; C) The diffusion 541 
profile when insulin solution is mounted on the top surface of the model. 542 
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C 
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B 
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 543 
Fig. 23 The diffusion profile of the passive diffusion and MNs enhanced diffusion based on the 544 
model of Fig. 22. In both cases, only permeation in viable epidermis is considered  545 
The numerical results for passive and MNs enhanced diffusion in VE are shown in Fig. 23. The 546 
cumulative concentrations of passive diffusion in the Fig. 22 are identical to the 2D results from 547 
Fig. 15 which indicates good consistency of the simulation. However, the concentrations of MNs 548 
enhanced diffusion of the 3D model are decreased due to the greater flux term in both horizontal 549 
and vertical directions. Based on this method, high quality 3D model of MNs treated skin can be 550 
achieved in the future if the acquired histological images are consistent and are of good quality. 551 
This paper aims to report on the development of the methodology and, therefore experimental 552 
results of 3D structured MNs will not be discussed. 553 
5. Conclusion 554 
Numerical simulation based on histological image using an new MATLAB program and COMSOL 555 
have been carried out which shows a great potential for accurate numerical modelling of MN 556 
enhanced drug delivery. The histological images provide the image of MNs created holes in the 557 
skin. This is hypothesised to be more accurate than simply assuming that the MN holes in the 558 
skin have the same shape and size as that of the of MNs’ geometry. The histological images 559 
indicate an accurate depth of the hole which is required for the numerical simulation. The 560 
developed algorithm converts the real images to simulation required coordinates. After importing 561 
these data into a numerical simulator (e.g., COMSOL), the diffusion analysis can be easily 562 
carried out. It is expected that the developed paradigm for numerical simulation of MN based 563 
delivery would help the researches to design more efficient MNs systems.  564 
  565 
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